301 related articles for article (PubMed ID: 30885251)
1. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
2. CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway.
Zhao N; Wang C; Guo P; Hou J; Yang H; Lan T; Zhou Y; Li J; Bhawal UK; Liu Y
Bioengineered; 2022 Apr; 13(4):10956-10972. PubMed ID: 35484984
[TBL] [Abstract][Full Text] [Related]
3. GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
Lin F; Xie YJ; Zhang XK; Huang TJ; Xu HF; Mei Y; Liang H; Hu H; Lin ST; Luo FF; Lang YH; Peng LX; Qian CN; Huang BJ
J Exp Clin Cancer Res; 2019 Apr; 38(1):152. PubMed ID: 30961661
[TBL] [Abstract][Full Text] [Related]
4. CCDC106 promotes non-small cell lung cancer cell proliferation.
Zhang X; Zheng Q; Wang C; Zhou H; Jiang G; Miao Y; Zhang Y; Liu Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(16):26662-26670. PubMed ID: 28460455
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation.
Zhou J; Qiao X; Xiao L; Sun W; Wang L; Li H; Wu Y; Ding X; Hu X; Zhou C; Zhang J
FEBS Lett; 2010 Mar; 584(6):1085-90. PubMed ID: 20159018
[TBL] [Abstract][Full Text] [Related]
6. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
[TBL] [Abstract][Full Text] [Related]
7. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z
Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694
[TBL] [Abstract][Full Text] [Related]
8. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
10. Dephosphorylation of p53 Ser 392 Enhances Trimethylation of Histone H3 Lys 9 via SUV39h1 Stabilization in CK2 Downregulation-Mediated Senescence.
Park JW; Bae YS
Mol Cells; 2019 Nov; 42(11):773-782. PubMed ID: 31617338
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
Munagala R; Kausar H; Munjal C; Gupta RC
Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
[TBL] [Abstract][Full Text] [Related]
12. HPV-CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing.
Zhi W; Wei Y; Lazare C; Meng Y; Wu P; Gao P; Lin S; Peng T; Chu T; Liu B; Ding W; Cao C; Wu P
J Med Virol; 2023 Jan; 95(1):e28009. PubMed ID: 35854676
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
14. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
15. Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.
Liang Y; Besch-Williford C; Benakanakere I; Hyder SM
Int J Oncol; 2007 Oct; 31(4):777-84. PubMed ID: 17786308
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
17. Premature senescence in human breast cancer and colon cancer cells by tamoxifen-mediated reactive oxygen species generation.
Lee YH; Kang BS; Bae YS
Life Sci; 2014 Mar; 97(2):116-22. PubMed ID: 24361399
[TBL] [Abstract][Full Text] [Related]
18. Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2.
Rao F; Cha J; Xu J; Xu R; Vandiver MS; Tyagi R; Tokhunts R; Koldobskiy MA; Fu C; Barrow R; Wu M; Fiedler D; Barrow JC; Snyder SH
Mol Cell; 2014 Apr; 54(1):119-132. PubMed ID: 24657168
[TBL] [Abstract][Full Text] [Related]
19. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
20. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
[Next] [New Search]
